These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 26783179)

  • 1. Structure guided design of potential inhibitors of human calcium-calmodulin dependent protein kinase IV containing pyrimidine scaffold.
    Naz H; Jameel E; Hoda N; Shandilya A; Khan P; Islam A; Ahmad F; Jayaram B; Hassan MI
    Bioorg Med Chem Lett; 2016 Feb; 26(3):782-788. PubMed ID: 26783179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis, and biological evaluation of pyrimidine derivatives as potential inhibitors of human calcium/calmodulin-dependent protein kinase IV.
    Jameel E; Naz H; Khan P; Tarique M; Kumar J; Mumtazuddin S; Ahamad S; Islam A; Ahmad F; Hoda N; Hassan MI
    Chem Biol Drug Des; 2017 May; 89(5):741-754. PubMed ID: 27809417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High throughput screening, docking, and molecular dynamics studies to identify potential inhibitors of human calcium/calmodulin-dependent protein kinase IV.
    Beg A; Khan FI; Lobb KA; Islam A; Ahmad F; Hassan MI
    J Biomol Struct Dyn; 2019 May; 37(8):2179-2192. PubMed ID: 30044185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding studies and biological evaluation of β-carotene as a potential inhibitor of human calcium/calmodulin-dependent protein kinase IV.
    Naz H; Khan P; Tarique M; Rahman S; Meena A; Ahamad S; Luqman S; Islam A; Ahmad F; Hassan MI
    Int J Biol Macromol; 2017 Mar; 96():161-170. PubMed ID: 27956097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of pH on the structure, function, and stability of human calcium/calmodulin-dependent protein kinase IV: combined spectroscopic and MD simulation studies.
    Naz H; Shahbaaz M; Bisetty K; Islam A; Ahmad F; Hassan MI
    Biochem Cell Biol; 2016 Jun; 94(3):221-8. PubMed ID: 27032767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Potential Inhibitors of Calcium/Calmodulin-Dependent Protein Kinase IV from Bioactive Phytoconstituents.
    Gupta P; Khan S; Fakhar Z; Hussain A; Rehman MT; AlAjmi MF; Islam A; Ahmad F; Hassan MI
    Oxid Med Cell Longev; 2020; 2020():2094635. PubMed ID: 32724490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis, anticancer activity and docking studies of novel 4-morpholino-7,8-dihydro-5H-thiopyrano[4,3-d]pyrimidine derivatives as mTOR inhibitors.
    Zhu W; Sun C; Xu S; Wu C; Wu J; Xu M; Zhao H; Chen L; Zeng W; Zheng P
    Bioorg Med Chem; 2014 Dec; 22(24):6746-54. PubMed ID: 25468038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, Docking Studies into CDK-2 and Anticancer Activity of New Derivatives Based Pyrimidine Scaffold and Their Derived Glycosides.
    Rahman AAHA; Nassar IF; Shaban AKF; El-Kady DS; Awad HM; El Sayed WA
    Mini Rev Med Chem; 2019; 19(13):1093-1110. PubMed ID: 30864522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis, anti-tumor activity, and molecular modeling of quinazoline and pyrido[2,3-d]pyrimidine derivatives targeting epidermal growth factor receptor.
    Hou J; Wan S; Wang G; Zhang T; Li Z; Tian Y; Yu Y; Wu X; Zhang J
    Eur J Med Chem; 2016 Aug; 118():276-89. PubMed ID: 27132165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Curcumin specifically binds to the human calcium-calmodulin-dependent protein kinase IV: fluorescence and molecular dynamics simulation studies.
    Hoda N; Naz H; Jameel E; Shandilya A; Dey S; Hassan MI; Ahmad F; Jayaram B
    J Biomol Struct Dyn; 2016; 34(3):572-84. PubMed ID: 25929263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hesperidin-CAMKIV interaction and its impact on cell proliferation and apoptosis in the human hepatic carcinoma and neuroblastoma cells.
    Naz H; Tarique M; Ahamad S; Alajmi MF; Hussain A; Rehman MT; Luqman S; Hassan MI
    J Cell Biochem; 2019 Sep; 120(9):15119-15130. PubMed ID: 31021496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dihydrobenzo[4,5]imidazo[1,2-a]pyrimidine-4-ones as a new class of CK2 inhibitors.
    Protopopov MV; Ostrynska OV; Starosyla SA; Vodolazhenko MA; Sirko SM; Gorobets NY; Bdzhola V; Desenko SM; Yarmoluk SM
    Mol Divers; 2018 Nov; 22(4):991-998. PubMed ID: 29845490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of novel 2,4-disubstituted pyrimidines as Aurora kinase inhibitors.
    Xu Y; Hao SY; Zhang XJ; Li WB; Qiao XP; Wang ZX; Chen SW
    Bioorg Med Chem Lett; 2020 Feb; 30(3):126885. PubMed ID: 31862411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-based design and synthesis of pyrimidine-4,6-diamine derivatives as Janus kinase 3 inhibitors.
    Yu RN; Chen CJ; Shu L; Yin Y; Wang ZJ; Zhang TT; Zhang DY
    Bioorg Med Chem; 2019 Apr; 27(8):1646-1657. PubMed ID: 30853331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pyrimidine-based pyrazoles as cyclin-dependent kinase 2 inhibitors: Design, synthesis, and biological evaluation.
    Vekariya MK; Vekariya RH; Brahmkshatriya PS; Shah NK
    Chem Biol Drug Des; 2018 Sep; 92(3):1683-1691. PubMed ID: 29767460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence of vanillin binding to CAMKIV explains the anti-cancer mechanism in human hepatic carcinoma and neuroblastoma cells.
    Naz H; Tarique M; Khan P; Luqman S; Ahamad S; Islam A; Ahmad F; Hassan MI
    Mol Cell Biochem; 2018 Jan; 438(1-2):35-45. PubMed ID: 28744811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Designing New Kinase Inhibitor Derivatives as Therapeutics Against Common Complex Diseases: Structural Basis of Microtubule Affinity-Regulating Kinase 4 (MARK4) Inhibition.
    Naz F; Shahbaaz M; Bisetty K; Islam A; Ahmad F; Hassan MI
    OMICS; 2015 Nov; 19(11):700-11. PubMed ID: 26565604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combining X-ray crystallography and molecular modeling toward the optimization of pyrazolo[3,4-d]pyrimidines as potent c-Src inhibitors active in vivo against neuroblastoma.
    Tintori C; Fallacara AL; Radi M; Zamperini C; Dreassi E; Crespan E; Maga G; Schenone S; Musumeci F; Brullo C; Richters A; Gasparrini F; Angelucci A; Festuccia C; Delle Monache S; Rauh D; Botta M
    J Med Chem; 2015 Jan; 58(1):347-61. PubMed ID: 25469771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of novel Bruton's tyrosine kinase (BTK) inhibitors bearing a pyrrolo[2,3-d]pyrimidine scaffold.
    Zhao X; Huang W; Wang Y; Xin M; Jin Q; Cai J; Tang F; Zhao Y; Xiang H
    Bioorg Med Chem; 2015 Feb; 23(4):891-901. PubMed ID: 25596757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Explicit treatment of active-site waters enhances quantum mechanical/implicit solvent scoring: Inhibition of CDK2 by new pyrazolo[1,5-a]pyrimidines.
    Hylsová M; Carbain B; Fanfrlík J; Musilová L; Haldar S; Köprülüoğlu C; Ajani H; Brahmkshatriya PS; Jorda R; Kryštof V; Hobza P; Echalier A; Paruch K; Lepšík M
    Eur J Med Chem; 2017 Jan; 126():1118-1128. PubMed ID: 28039837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.